Form 8-K - Current report:
SEC Accession No. 0001628280-26-048347
Filing Date
2026-07-15
Accepted
2026-07-15 16:58:01
Documents
21
Period of Report
2026-07-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cbio-20260714.htm   iXBRL 8-K 42114
2 EX-1.1 exhibit11underwritingagree.htm EX-1.1 385788
3 EX-4.1 exhibit41formofpre-fundedw.htm EX-4.1 107360
4 EX-5.1 exhibit51walkersopiniondeal.htm EX-5.1 44157
5 EX-5.2 exhibit52lathamopiniondeal.htm EX-5.2 20283
6 EX-99.1 exhibit991launchpressrelea.htm EX-99.1 10094
7 EX-99.2 exhibit992pricingpressrele.htm EX-99.2 10791
11 image_0.jpg GRAPHIC 16232
12 image_0a.jpg GRAPHIC 10826
13 image_1.jpg GRAPHIC 27416
14 image_2.jpg GRAPHIC 13251
  Complete submission text file 0001628280-26-048347.txt   952418

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbio-20260714.xsd EX-101.SCH 1800
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbio-20260714_lab.xml EX-101.LAB 21885
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbio-20260714_pre.xml EX-101.PRE 12520
24 EXTRACTED XBRL INSTANCE DOCUMENT cbio-20260714_htm.xml XML 2716
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 261177934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)